Management & Regulatory

Revolutionizing Biomanufacturing: Real-Time Analytics with Laser Force Cytology
Management & Regulatory Revolutionizing Biomanufacturing: Real-Time Analytics with Laser Force Cytology

In today's rapidly evolving field of biomanufacturing, traditional methods often fall short of the rigorous demands for real-time data and consistent product quality. Laser Force Cytology (LFC) has emerged as an innovative, label-free technology that offers a transformative approach to

Innovent Biologics Faces Investor Backlash Over Misvalued Stake Sale
Management & Regulatory Innovent Biologics Faces Investor Backlash Over Misvalued Stake Sale

Innovent Biologics Inc. (1801.HK), a significant player in the Chinese biopharmaceutical sector, recently faced harsh backlash from investors due to a misstep in its strategy. The company aimed to strengthen its executives' dedication to its international unit, Fortvita, by selling a stake to the

How Is Celltrion Expanding Zymfentra Access for US Patients?
Management & Regulatory How Is Celltrion Expanding Zymfentra Access for US Patients?

In recent developments, Celltrion USA has significantly expanded the availability of its subcutaneous treatment for Crohn's disease and ulcerative colitis, Zymfentra, now accessible to 26 million patients across the United States. This milestone achievement is a result of the company’s strategic

Gates Foundation Funds ApiJect to Boost Affordable Injectors for LMICs
Management & Regulatory Gates Foundation Funds ApiJect to Boost Affordable Injectors for LMICs

ApiJect Systems Corp., a public-benefit medical technology company, has recently secured an initial grant of $425,000 from the Bill & Melinda Gates Foundation. This significant funding aims to support the design and development of low-cost Prefilled ApiJect Injectors to make single-use prefilled

Viking's Obesity Drug Shows Promising Results Amid Competitive Market
Management & Regulatory Viking's Obesity Drug Shows Promising Results Amid Competitive Market

The recent results of a clinical trial for an oral obesity drug developed by Viking Therapeutics have generated significant interest. The drug has shown promise in early-phase trials, capturing the attention of Wall Street analysts and investors alike. The study results, revealed at a medical

Choosing Between BizDevOps and CoE Models for Pharma IT Efficiency
Management & Regulatory Choosing Between BizDevOps and CoE Models for Pharma IT Efficiency

In the pharmaceutical industry, IT organizations face a critical decision when managing unified clinical development platforms: whether to adopt a product-centric BizDevOps model or a centralized Center of Excellence (CoE) model. This choice is pivotal as pharmaceutical companies strive to bring

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later